Medicines (Labelling) (Amendment) Regulations 2016

Status:

Published in Subsidiary Legislation Supplement
on 31 Oct 2016

No. S 545

Medicines Act

(CHAPTER 176)

Medicines (Labelling) (Amendment)
Regulations 2016

In exercise of the powers conferred by section 44 of the Medicines Act, the Minister for Health makes the following Regulations:

Citation and commencement

1. These Regulations are the Medicines (Labelling) (Amendment) Regulations 2016 and come into operation on 1 November 2016.

Deletion of regulations 2 and 5

2. Regulations 2 and 5 of the Medicines (Labelling) Regulations (Rg 5) are deleted.

New regulation 3A

3. The Medicines (Labelling) Regulations are amended by inserting, immediately after regulation 3, the following regulation:

“Scope of Regulations

3A. These Regulations do not apply to —

(a)	Chinese proprietary medicines; and
(b)	any medicinal product (other than any Chinese proprietary medicine) that is clinical research material as defined in regulation 2 of the Medicines (Medicinal Products as Clinical Research Materials) Regulations 2016 (G.N. No. S 336/2016).”.

Made on 25 October 2016.

CHAN HENG KEE

Permanent Secretary,
Ministry of Health,
Singapore.

[HSA/LPPD/711:12/72-001; AG/LEGIS/SL/176/2015/6 Vol. 1]

Search within Legislation